ROC-ing along: Evaluation and interpretation of receiver operating characteristic curves
JV Carter, J Pan, SN Rai, S Galandiuk - Surgery, 2016 - Elsevier
Background It is vital for clinicians to understand and interpret correctly medical statistics as
used in clinical studies. In this review, we address current issues and focus on delivering a …
used in clinical studies. In this review, we address current issues and focus on delivering a …
The sacred lotus (Nelumbo nucifera)– phytochemical and therapeutic profile
…, D Mukherjee, AK Maji, S Rai… - Journal of Pharmacy …, 2009 - academic.oup.com
Objectives Nelumbo nucifera Gaertn. (Nymphaeaceae), also known as sacred lotus, is a
well known medicinal plant. This article reviews the traditional uses, phytochemistry and …
well known medicinal plant. This article reviews the traditional uses, phytochemistry and …
Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer's disease: understanding the therapeutics strategies
Synapses are formed by interneuronal connections that permit a neuronal cell to pass an
electrical or chemical signal to another cell. This passage usually gets damaged or lost in most …
electrical or chemical signal to another cell. This passage usually gets damaged or lost in most …
[HTML][HTML] Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma
…, C Herbaux, JM Burke, M Matasar, S Rai… - … England Journal of …, 2022 - Mass Medical Soc
Background Diffuse large B-cell lymphoma (DLBCL) is typically treated with rituximab,
cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). However, only 60% of …
cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). However, only 60% of …
[HTML][HTML] Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Background To mitigate the effects of COVID-19, a vaccine is urgently needed. BBV152 is a
whole-virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …
whole-virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
Background We report the clinical efficacy against COVID-19 infection of BBV152, a whole
virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …
virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …
[HTML][HTML] Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3 …
Background BBV152 is a whole-virion inactivated SARS-CoV-2 vaccine (3 μg or 6 μg)
formulated with a toll-like receptor 7/8 agonist molecule (IMDG) adsorbed to alum (Algel). We …
formulated with a toll-like receptor 7/8 agonist molecule (IMDG) adsorbed to alum (Algel). We …
Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non–germinal center B-cell diffuse large B …
…, O Samoilova, C Suh, S Leppä, S Rai… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE Ibrutinib has shown activity in non–germinal center B-cell diffuse large B-cell
lymphoma (DLBCL). This double-blind phase III study evaluated ibrutinib and rituximab plus …
lymphoma (DLBCL). This double-blind phase III study evaluated ibrutinib and rituximab plus …
Prevalence of orthostatic hypotension in Parkinson's disease
JM Senard, S Rai, M Lapeyre-Mestre… - Journal of Neurology …, 1997 - jnnp.bmj.com
OBJECTIVES To investigate the prevalence of orthostatic hypotension and the nature of the
postural events related to a fall in blood pressure in patients with Parkinson’s disease. …
postural events related to a fall in blood pressure in patients with Parkinson’s disease. …
POLYRATE 4: A new version of a computer program for the calculation of chemical reaction rates for polyatomics
…, BC Garrett, R Steckler, AD Isaacson, SN Rai… - Computer Physics …, 1992 - Elsevier
… reaction coordinate s, and s,~(T) is the location of the variational transition state at temperature
T. Note that the origin, s = 0, of the s coordinate is defined to be at the saddle point, and s* …
T. Note that the origin, s = 0, of the s coordinate is defined to be at the saddle point, and s* …